NCT00022243View on ClinicalTrials.gov

T138067 in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer That Has Not Responded to Previous Chemotherapy

PHASE2UnknownINTERVENTIONAL
Timeline

Start Date

October 31, 2000

Conditions
Lung Cancer
Interventions
DRUG

batabulin sodium

Trial Locations (2)

94143-0128

UCSF Cancer Center and Cancer Research Institute, San Francisco

37232-6838

Vanderbilt-Ingram Cancer Center, Nashville

Sponsors

Lead Sponsor

Tularik
All Listed Sponsors
lead

Tularik

INDUSTRY

NCT00022243 - T138067 in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer That Has Not Responded to Previous Chemotherapy | Biotech Hunter | Biotech Hunter